Home/Filings/4/0000899140-24-001318
4//SEC Filing

SUVRETTA CAPITAL MANAGEMENT, LLC 4

Accession 0000899140-24-001318

CIK 0001808898other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:36 PM ET

Size

27.6 KB

Accession

0000899140-24-001318

Insider Transaction Report

Form 4
Period: 2024-12-03
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-03$9.60/sh+37,190$357,0247,957,365 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-03$9.60/sh+4,810$46,176955,124 total(indirect: See footnotes)
Averill Master Fund, Ltd.
Director10% Owner
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-03$9.60/sh+37,190$357,0247,957,365 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-03$9.60/sh+4,810$46,176955,124 total(indirect: See footnotes)
Cowen Aaron
10% Owner
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-03$9.60/sh+4,810$46,176955,124 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-03$9.60/sh+37,190$357,0247,957,365 total(indirect: See footnotes)
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-03$9.60/sh+4,810$46,176955,124 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-03$9.60/sh+37,190$357,0247,957,365 total(indirect: See footnotes)
Footnotes (3)
  • [F1]Notes are included on Exhibit 99.1.
  • [F2]Notes are included on Exhibit 99.1.
  • [F3]Notes are included on Exhibit 99.1.

Issuer

Benitec Biopharma Inc.

CIK 0001808898

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001569064

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:36 PM ET
Size
27.6 KB